Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive LandscapeDelveInsight, the leading market research and consulting company has added a new report “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2015” to its portfolio.
By: DelveInsight Business Research · 200+ products and 60+ different technologies along with 160+ companies actively involved in drug development. There are 5 drugs in phase III, 17 in phase II, 44 in phase I, 83 in pre-clinical, 33 in discovery, 13 in dormant and 18 in discontinued. · Seattle Geneticsis developing a lead product Brentuximab Vedotin which is in Phase III. · R&D activities and technologies used along with the pipeline molecules in development. · Therapeutic assessments by molecule types, route of administration, monotherapy and combination products. · Information related to collaborations, in-licensing and out-licensing deals. DelveInsights, Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2015report provides the in-depth analysis of Antibody Drug Conjugate Landscape across the globe. Therefore the report on Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provide information on chemical, technology information and comparative analysis at various stages. In addition, it helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight is offering the Report at a price of USD 3450 as a single user license, USD 6900 as a site license and USD 10000 as a Global/Enterprise License. For more information on Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2015report, email at info@delveInsight.com About Us DelveInsight is a leading Business Consulting and Market Research Firm. They help clients to find answers relevant to their business, facilitating decision-making; End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|